Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasm Metastasis
×
liposomal doxorubicin
×
Clear all
Filters
3
NCT07213804
2026-04-17
FRAmework-01
Eli Lilly and Company
Phase 3
Recruiting
1,080 enrolled
NCT04895358
2026-03-11
KEYNOTE-B49
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
340 enrolled